BALPHARMA2023-07-012023-09-30 BALPHARMA2023-07-012023-09-30 BALPHARMA2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member BALPHARMA2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member BALPHARMA2023-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524824 BALPHARMA NOTLISTED Bal Pharma Limited Equity 2023-04-01 2024-03-31 2023-11-08 2023-10-20 INR Lakhs Half yearly 16:45:00 17:40:00 2023-11-08 2023-11-08 true Cash Flow Indirect Not applicable Single segment PHARMACEUTICLES 2023-07-01 2023-09-30 Unaudited Consolidated 925427000.00 1421000.00 926848000.00 502195000.00 32561000.00 -1611000.00 152985000.00 38212000.00 24192000.00 162321000.00 910855000.00 15993000.00 0.00 15993000.00 9857000.00 -3558000.00 6299000.00 0.00 9694000.00 0.00 0.00 0.00 0.00 9694000.00 0.00 9694000.00 9457000.00 237000.00 0.00 0.00 156898000.00 10 0.62 0.62 0.00 0.00 0.62 0.62 1. The above unaudited consolidated financial results of the company have been reviewed by the audit committee and approved by the board of directors at thrie respective meetings held on 08.11.2023. 2. The consolidated financial results have been prepared inn accordance with the companies ( Indian accountinng standdards ) Rules 2015 . IND AS prescribed under sectionn 133 of Companies Act 2013. 3. The group has not received any intimation or information with regard to its vendores registration as MSME's . Accordingly the entire dues to vendors has been classified as payable to other then MSME's. 4. The Company has outstanding recoverability of Rs.859.89 Lakhs and 152.23 lakhs from its subsidiaries Lifezen helathcare Pvt Ltd and Balance Clinics LLP. Thes said subsidiariees has incurred losses and have a negative net worth. However the management is confdent that with the infustion of additional funds and introduction of new brands and renewed marketing internal restructing , the Company can be revieved and the amounts can be recovered. 5. Figures for the year ended March 31,2023 and 31st March 2022 are the balancinng figures between the audited figures in respect of the full financial year and unaudited published year todate figures upto the thired of the relevant financial year which were subjected to limited review by the sttautory auditors. 6. The Company has only one reportable segment i.e Pharmaceuticles . 7. The Company has filed its application with NCLT for the merger of Golden Drugs Pvt Ltd a wholly owned subsidiary of the company. 8. The Company has made the grant of 4,16,500 stock options during the year 2021.22 and these stock options will vest in line with the scheme. 9. Previous year figures have been regrouped or rearranged wherever considered necessary to conform to the period presentation. Single segment 2023-04-01 2023-09-30 Unaudited Consolidated 1629301000.00 2988000.00 1632289000.00 917649000.00 47749000.00 -44014000.00 294837000.00 74574000.00 49534000.00 271661000.00 1611990000.00 20299000.00 0.00 20299000.00 15259000.00 -5601000.00 9658000.00 0.00 10641000.00 0.00 0.00 0.00 0.00 10641000.00 0.00 10641000.00 10300000.00 341000.00 0.00 0.00 156898000.00 10 0.68 0.68 0.00 0.00 0.68 0.68 Other Expenses 162321000.00 Other Expenses 271661000.00 -528000.00 610850000.00 695000.00 0.00 38286000.00 112376000.00 0.00 0.00 0.00 0.00 0.00 975000.00 31229000.00 32204000.00 21666000.00 39134000.00 855211000.00 1056651000.00 0.00 1029289000.00 13662000.00 70131000.00 10808000.00 15601000.00 1139491000.00 2025000.00 245015000.00 2443182000.00 0.00 0.00 3298393000.00 156899000.00 475657000.00 632556000.00 632028000.00 280999000.00 0.00 22769000.00 303768000.00 53624000.00 23090000.00 0.00 -209493000.00 170989000.00 1129660000.00 973115000.00 218197000.00 2320972000.00 17036000.00 6446000.00 150922000.00 0.00 2495376000.00 0.00 0.00 2666365000.00 3298393000.00 -6641000.00 -748000.00 0.00 -1564000.00 74571000.00 0.00 689000.00 45452000.00 0.00 0.00 0.00 -76602000.00 -153515000.00 -45792000.00 -2068000.00 7602000.00 24954000.00 167645000.00 -4701000.00 3177000.00 -19240000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 51699000.00 71998000.00 0.00 0.00 0.00 0.00 0.00 71998000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 71998000.00 0.00 71998000.00 0.00 71998000.00